PATENT CLAIM ANALYSIS

Application Number: 15861974
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "182000"]

Abstract:
This invention relates to Huntington's disease and more specifically to methods for inhibiting the development of or treating Huntington's disease by administering estrogen, testosterone, precursors thereof or combinations thereof.

Claim (Index 17):
The method of  claim 15 , wherein the Unified Huntington's Disease Rating Scale (UHDRS) score remains about the same or does not increase.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.25926
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12961250', '14334643', '11627978', '14961689', '13988605']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.776838040490378
- 35 USC 102 Novelty (BERT): 0.6077034618188983
- Combined Prediction Score: 0.75992458262323
- Mean Citation Score: 394.770004
- Max Citation Score: 610.4043
- Similarity Product: 433.0311056835652

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test